| dc.description.abstract | Due to the inseparable relationship between global climate change and greenhouse gas emissions, the global attention to the issue of greenhouse gas emissions has deepened the management and control of corporate carbon footprints by government organizations, which has also become an issue that enterprises need to face in the next generation. In the future, products with the concept of energy saving, carbon reduction and environmental protection should of course be favored by consumers and receive government incentives and subsidies. In the medical autoinjector industry, few people have conducted carbon foot surveys and researches in this industry.
This study uses the Life Cycle Assessment (LCA) method to conduct inventory analysis in each stage of the life cycle of medical auto-injectors, supplemented by empirical analysis of medical autoinjector energy consumption cases and case studies. The carbon footprint generated in the cycle is mainly in the stages of plastic raw materials, manufacturing, transportation and logistics. This study explores the distribution of carbon footprints in each stage of its life cycle. The results of the research analysis show that in each stage of the medical auto-injector life cycle in this study, if the number of medical autoinjectors produced in one year′s shipment is evaluated, the highest carbon footprint is the energy used in the production of the auto-injector. Consumption and raw materials, packaging consumables account for 98% of the overall carbon footprint, and only 2% for transport logistics. The least carbon footprint is water and electricity consumption, accounting for about 15% of the overall manufacturing process, mainly due to the recycling of water resources. In the case study, it was also found that the production consumables such as PS、PET Tray and cartons used to hold sub-assembly products, despite being very light in weight, account for a relatively high carbon footprint, accounting for about 29% of the total production process. Therefore, if an alternative packaging material with a lower carbon footprint is used, this will effectively reduce the carbon footprint of the production of medical auto-injectors, in order to achieve the goal of energy saving and carbon reduction. | en_US |